-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Compass Therapeutics, Inc. quarterly Weighted Average Number of Shares Outstanding, Diluted history and growth rate for Q3 2024.
- Compass Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 138M shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)